chr7-77196947-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006682.3(FGL2):c.652G>A(p.Ala218Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000906 in 1,612,112 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006682.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGL2 | NM_006682.3 | c.652G>A | p.Ala218Thr | missense_variant | 2/2 | ENST00000248598.6 | NP_006673.1 | |
CCDC146 | NM_020879.3 | c.156+29123C>T | intron_variant | ENST00000285871.5 | NP_065930.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGL2 | ENST00000248598.6 | c.652G>A | p.Ala218Thr | missense_variant | 2/2 | 1 | NM_006682.3 | ENSP00000248598.5 | ||
CCDC146 | ENST00000285871.5 | c.156+29123C>T | intron_variant | 1 | NM_020879.3 | ENSP00000285871.4 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000810 AC: 20AN: 246970Hom.: 0 AF XY: 0.0000821 AC XY: 11AN XY: 134020
GnomAD4 exome AF: 0.0000801 AC: 117AN: 1459938Hom.: 2 Cov.: 30 AF XY: 0.0000840 AC XY: 61AN XY: 726446
GnomAD4 genome AF: 0.000191 AC: 29AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74416
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at